• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • News
  • Lifestyle
  • Wellness
  • Cuisine
  • Product Reviews
  • Subscribe
Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Emerald Media News Subscription
  • Print Magazines
  • 100+ Minority-Owned Companies to Support
  • No Pipe, No Problem
  • Blunt vs. Joint
  • The Cost of Cannabis in Each State
  • Calculating Your Edibles Dosage
  • Flintts Mouthwatering Mints

Federal Court Reconsiders Cannabis’ Classification as a Schedule 1 Drug

June 18, 2019 by Rita Thompson Leave a Comment

Back in 2017, a group of medical cannabis patients and advocates filed a lawsuit against the United States DEA challenging the classification of cannabis as a Schedule 1 drug. With current knowledge of cannabis’s benefits becoming more and more widespread, the collection of plaintiffs argued on the basis that cannabis’s health and economic benefits warrant reconsideration of the plant’s current classification.

Although the federal district court originally dismissed the case, things are looking up for users and advocates alike as the appeals court has refused to dismiss the case following the plaintiffs’ appeal of the original ruling.

As of May 30, new opinions are pressuring the DEA into conducting an administrative review as plaintiffs continue to insist on the health threats that the current scheduling of cannabis brings.

Alexis Bortell and Jagger Cotte, both of whom suffer from severe medical problems, argued that cannabis has, in fact, saved their lives. A mid-sesh statement that many of us have made now and again is all the more real for these two. Having exhausted every traditional treatment option, cannabis has been the only glimmer of light, offering comfort and relief in their constant health battles.  However, the current Schedule 1 classification has prevented the plaintiffs from traveling with their medication, and if this classification is not modified, their health will continue to be at risk. Noting cannabis’s medicinal value to many plaintiffs, the court is pushing for a speedy review. “Plaintiffs should not be required to live indefinitely with uncertainty about their access to allegedly life-saving medication,” the judges wrote.

While the Second Circuit could have simply re-dismissed the case, the court has noted the significant evidence backing cannabis’s medical value. Further, while the court noted that it would not order the DEA to reconsider cannabis’s current status, it will continue to monitor the situation and take necessary action if the DEA fails to act promptly.

While it’s still unclear whether or not the DEA will act, this consideration provides a giant stepping stone for medical cannabis business and research.

Filed Under: Current, Lifestyle Tagged With: cannabis, Main Gallery Images

Reader Interactions

Leave a Reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Advertise Here

Categories

Sustainability

seaweed naturals

SeaWeed Naturals Combines the Power of Seaweed with Cannabis to Further Ocean Restoration

April 3, 2022 By Maggie Horton

fungi climate change

Research Finds Fungi Help Ease Climate Change and Benefit the Environment

March 30, 2022 By Julia Meyer

climate crisis and the pandemic

“We Can Act:” What Bending the COVID-19 Curve Teaches Us About the Climate Crisis

April 21, 2020 By Melissa Hutsell

Footer

  • Subscribe
  • About
  • Contact
  • Privacy
  • Press

Recent

  • Up in Smoke: An Interview with Smoke Proper, the Trailblazing Cannabis Accessory Brand
  • Priscilla Vilchis and Lil Kim Launch Aphrodisiak: A Cannabis Brand Focused on Sensuality, Social Justice, and Inclusivity
  • First Latina CEO of a Cannabis Company Partners with Music Industry Trailblazer Lil Kim to Launch Aphrodisiak Brand
  • Aphrodisiak: The New Female-Led Cannabis Brand Empowering Women and Promoting Inclusivity
  • Las Vegas Welcomes Aphrodisiak

Search

Copyright © 2023 · The Emerald™ · News & Lifestyle Magazine

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Cannabis News and Culture Magazine
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.